Lindemann, M.; Dukic-Stefanovic, S.; Hinz, S.; Deuther-Conrad, W.; Teodoro, R.; Juhl, C.; Steinbach, J.; Brust, P.; Müller, C.E.; Wenzel, B.
Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A2B Receptor Binding Affinity. Pharmaceuticals 2021, 14, 485.
https://doi.org/10.3390/ph14050485
AMA Style
Lindemann M, Dukic-Stefanovic S, Hinz S, Deuther-Conrad W, Teodoro R, Juhl C, Steinbach J, Brust P, Müller CE, Wenzel B.
Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A2B Receptor Binding Affinity. Pharmaceuticals. 2021; 14(5):485.
https://doi.org/10.3390/ph14050485
Chicago/Turabian Style
Lindemann, Marcel, Sladjana Dukic-Stefanovic, Sonja Hinz, Winnie Deuther-Conrad, Rodrigo Teodoro, Cathleen Juhl, Jörg Steinbach, Peter Brust, Christa E. Müller, and Barbara Wenzel.
2021. "Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A2B Receptor Binding Affinity" Pharmaceuticals 14, no. 5: 485.
https://doi.org/10.3390/ph14050485
APA Style
Lindemann, M., Dukic-Stefanovic, S., Hinz, S., Deuther-Conrad, W., Teodoro, R., Juhl, C., Steinbach, J., Brust, P., Müller, C. E., & Wenzel, B.
(2021). Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A2B Receptor Binding Affinity. Pharmaceuticals, 14(5), 485.
https://doi.org/10.3390/ph14050485